🟢 Opus Genetics is trading 5.19% up in pre-market with no direct catalyst identified

Opus Genetics is trading at $4.05, up 5.19% after rising from the $3.85 August 27 close; no direct catalyst has been confirmed.

• No new company-specific announcement was identified for August 28.
• The latest major release involved completing Phase 3 enrollment on August 3.
• Nvidia-led technology strength may support broader risk appetite, but today’s index futures are mixed.